Dacomitinib (Standard)
Dacomitinib (Standard) is the analytical standard of Dacomitinib. This product is intended for research and analytical applications. Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively[1].
Product Specifications
CAS Number
1110813-31-4
Product Name Alternative
PF-00299804 (Standard) ; PF-299804 (Standard)
UNSPSC
12352005
Target
Apoptosis; EGFR; Reference Standards
Type
Reference Standards
Related Pathways
Apoptosis; JAK/STAT Signaling; Others; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dacomitinib-standard.html
Smiles
O=C(/C=C/CN1CCCCC1)NC2=CC3=C(C=C2OC)N=CN=C3NC4=CC=C(C(Cl)=C4)F
Molecular Formula
C24H25ClFN5O2
Molecular Weight
469.94
References & Citations
[1]Engelman JA, et al. PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to ZD1839. Cancer Res. 2007 Dec 15;67 (24) :11924-32.|[2]Kalous O, et al. Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor, inhibits proliferation of HER2-amplified breast cancer cell lines resistant to Anti-Human HER2 and GW572016. Mol Cancer Ther. 2012 Sep;11 (9) :1978-87.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY400778 100 µg
hnRNP A1 (HNRNPA1) (NM_002136) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC051331-1ML 1x 1 mL
Isotype Control, Mouse IgG1 Kappa (IGG1/1331), CF405M Conjugate, 0.1 mg/mL
Sign In for Pricing
View Details 
